Drug Profile
Research programme: apoptosis-detecting imaging agents - Medtronic/NewSouth Innovations Pty
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of New South Wales
- Developer Medtronic
- Class Imaging agents; Radiopharmaceutical diagnostics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer(Diagnosis) in USA
- 08 Oct 2007 Early research in Cancer in USA (unspecified route)